How a three-pronged IP strategy could help biosimilar manufacturers

Biosimilar manufacturers should assess the patent portfolios of third parties, determine whether they can obtain patent protection of their own, and identify opportunities for licensing, to take advantage of the opportunities for growth in the market in the years ahead.

Read Complete Article

MITLA is a member of the INPLP

    Subscribe for the latest
    IT Law updates

    Receive the latest IT Law updates straight to your inbox, gain access to our exclusive industry events, keep up to date with MITLA.